Skeletal regenerative medicine promises to mitigate age-related bone loss and support fracture healing but requires manipulation of biological properties of osteogenic progenitor cells. Osteogenic cells must sustain their phenotype during lineage-expansion yet undergo a number of mitotic cell cycles to generate the requisite number of cells for proper tissue-organization. The proposed study will examine fundamental mechanisms that ensure cells retain a post-mitotic molecular memory of the bone phenotype. The central hypothesis of our study is that key mRNAs for osteogenic factors are passed on to daughter cells during mitosis as a component of a non-genomic epigenetic mechanism and that selected microRNAs (miRs) attenuate the translation of these transmitted mRNAs. Our hypothesis is based on a robust set of preliminary data showing that the osteogenic master regulator Runx2 is controlled by mitotic miRs in osteoblastic cell lines. Based on these and other preliminary data, we will (i) characterize the full complement of miRs that suppress expression of Runx2 in proliferating osteogenic cells, as well as begin characterization of mRNAs and cognate miRs during mitosis;(ii) examine miR dependent changes in fidelity of cell growth, survival and lineage-direction in proliferating osteoblasts, and (iii) characterize the physiological role of selected mitosis-related miRs during skeletal development in vivo. Validation of this concept would (i) establish a major new dimension in cell cycle regulation, (ii) reveal a previously unrecognized function for miRs during mitosis, (iii) define a novel molecular mechanism for biological control of gene expression in lineage-committed cells, and (iv) identify specific miRs that are transmitted to osteogenic progeny cells upon mitosis ('mito-miRs'). From a molecular therapeutic perspective, these miRs permit generation of epigenomic agents that control cellular inheritance by targeting cell fate determining factors which mediate mesenchymal stem cell expansion and differentiation.

Public Health Relevance

Bone formation requires expansion and differentiation of osteoprogenitor cells. Osteogenic cells pass on genetic (chromosomes) and epigenetic information (e.g., CpG methylation, histone codes and bookmarking by transcription factors) to progeny cells to maintain growth potential and osteogenic phenotype identity. We will characterize a fundamentally novel RNA based epigenetic mechanism involving mitotic co-transmission of mRNAs and cognate microRNAs during mitosis.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Research Project (R01)
Project #
Application #
Study Section
Skeletal Biology Development and Disease Study Section (SBDD)
Program Officer
Chen, Faye H
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Mayo Clinic, Rochester
United States
Zip Code
Dudakovic, Amel; Camilleri, Emily T; Lewallen, Eric A et al. (2015) Histone deacetylase inhibition destabilizes the multi-potent state of uncommitted adipose-derived mesenchymal stromal cells. J Cell Physiol 230:52-62
Galea, Gabriel L; Meakin, Lee B; Savery, Dawn et al. (2015) Planar cell polarity aligns osteoblast division in response to substrate strain. J Bone Miner Res 30:423-35
Cho, Young-Dan; Yoon, Won-Joon; Kim, Woo-Jin et al. (2014) Epigenetic modifications and canonical wingless/int-1 class (WNT) signaling enable trans-differentiation of nonosteogenic cells into osteoblasts. J Biol Chem 289:20120-8
Eirin, Alfonso; Riester, Scott M; Zhu, Xiang-Yang et al. (2014) MicroRNA and mRNA cargo of extracellular vesicles from porcine adipose tissue-derived mesenchymal stem cells. Gene 551:55-64
Okolicsanyi, Rachel K; van Wijnen, Andre J; Cool, Simon M et al. (2014) Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity. J Cell Biochem 115:967-76
Dudakovic, Amel; Camilleri, Emily; Riester, Scott M et al. (2014) High-resolution molecular validation of self-renewal and spontaneous differentiation in clinical-grade adipose-tissue derived human mesenchymal stem cells. J Cell Biochem 115:1816-28
van Wijnen, Andre J; van de Peppel, Jeroen; van Leeuwen, Johannes P et al. (2013) MicroRNA functions in osteogenesis and dysfunctions in osteoporosis. Curr Osteoporos Rep 11:72-82
Dudakovic, Amel; Evans, Jared M; Li, Ying et al. (2013) Histone deacetylase inhibition promotes osteoblast maturation by altering the histone H4 epigenome and reduces Akt phosphorylation. J Biol Chem 288:28783-91
Dombrowski, Christian; Helledie, Torben; Ling, Ling et al. (2013) FGFR1 Signaling Stimulates Proliferation of Human Mesenchymal Stem Cells by Inhibiting the Cyclin-Dependent Kinase Inhibitors P21(Waf1) and P27(Kip1.) Stem Cells :
van der Deen, Margaretha; Taipaleenmaki, Hanna; Zhang, Ying et al. (2013) MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma. J Biol Chem 288:21307-19

Showing the most recent 10 out of 45 publications